NASDAQ: AIFFFirefly Neuroscience Revenue
Firefly Neuroscience revenue was $1.14M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $412.0k, up 6.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIFF annual revenue was $1.1M, with 957.4% growth year-over-year.
AIFF past revenue growth
How has AIFF's revenue growth performed historically?
Company
957.41%
Industry
8.32%
Market
37.91%
AIFF's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AIFF's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AIFF's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
AIFF revenue history
Current Revenue
$1.1M
Current Earnings
-$24.5M
Current Profit Margin
-2,148.1%
Be the first to know when AIFF announces revenue.
AIFF Revenue History By Year
| AIFF Yearly Revenue | AIFF Revenue | AIFF Change | AIFF Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $1.14M | $1.03M | +957.41% |
| 2024-12-31 | $108.00k | -$390.00k | -78.31% |
| 2023-12-31 | $498.00k | -$10.52M | -95.48% |
| 2022-12-31 | $11.02M | -$4.01M | -26.68% |
| 2021-12-31 | $15.03M | $1.13M | +8.13% |
| 2020-12-31 | $13.90M | $3.74M | +36.77% |
| 2019-12-31 | $10.16M | $1.23M | +13.78% |
| 2018-12-31 | $8.93M | -$1.71M | -16.04% |
| 2017-12-31 | $10.64M | $3.91M | +58.14% |
| 2016-12-31 | $6.73M | $514.21k | +8.27% |
| 2015-12-31 | $6.21M | $431.12k | +7.45% |
| 2014-12-31 | $5.78M | -$1.69M | -22.66% |
| 2013-12-31 | $7.48M | $420.83k | +5.96% |
| 2012-12-31 | $7.06M | -$763.22k | -9.76% |
| 2011-12-31 | $7.82M | $960.83k | +14.01% |
| 2010-12-31 | $6.86M | $148.57k | +2.21% |
| 2009-12-31 | $6.71M | $17.92k | +0.27% |
| 2008-12-31 | $6.69M | -$3.26M | -32.75% |
| 2007-12-31 | $9.95M | $493.90k | +5.22% |
| 2006-12-31 | $9.46M | -$1.31M | -12.18% |
| 2005-12-31 | $10.77M | $1.46M | +15.72% |
| 2004-12-31 | $9.31M | $3.94M | +73.39% |
| 2003-12-31 | $5.37M | -$449.50k | -7.73% |
| 2002-12-31 | $5.82M | -$268.34k | -4.41% |
| 2001-12-31 | $6.09M | $315.83k | +5.47% |
| 2000-12-31 | $5.77M | -$3.82M | -39.80% |
| 1999-12-31 | $9.59M | -$5.75M | -37.48% |
| 1998-12-31 | $15.33M | $7.25M | +89.74% |
| 1997-12-31 | $8.08M | -$3.14M | -27.97% |
| 1996-12-31 | $11.22M | -$4.48M | -28.53% |
| 1995-12-31 | $15.70M | -$992.64k | -5.95% |
| 1994-12-31 | $16.69M | N/A | N/A |
Firefly Neuroscience Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.